Background
Current surgical treatment of primary melanoma is uniform for all histo-subtypes, although certain types of melanoma, such as acral lentiginous melanoma (ALM), carry a poor prognosis. No study has explored the effectiveness of standard melanoma treatment guidelines in ALM compared to non-acral melanoma (NAM).
Methods
Study subjects were identified from a prospectively enrolled database of primary melanoma patients at Blinded for Review Purposes. ALM patients were matched to NAM patients (1:3) by gender and melanoma stage, including substage (ALM=61, NAM=183). All patients received standard of care treatment. Recurrence and survival outcomes in both cohorts were compared.
Results
ALM histologic subtype was an independent negative predictor of recurrence-free survival (HR = 2.45, p < 0.001) and melanoma-specific survival (HR= 2.64, p = 0.001) compared to NAM. Recurrence was significantly more common in ALM compared to NAM (49% versus 30%, p=0.007). In tumors less than 2mm in thickness, there was a significantly higher recurrence rate in ALM versus NAM (p=0.048). There was no significant difference in recurrence in tumors greater than 2mm (p= 0.12). Of note, the rate of loco-regional recurrence was nearly double in ALM compared to NAM (p=0.001).
Conclusions
Our data revealed a high rate of loco-regional failure in ALM compared to NAM when controlling for AJCC stage. Our results question whether ALM may require more aggressive surgical treatment than non- acral cutaneous melanomas of equal thickness, particularly in tumors less than 2mm thick. Revision of surgical margin recommendations based on larger multicenter cohorts may need to be considered.